These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2133597)

  • 1. [Immunosuppressive factors in the blood in patients during the development of various kidney diseases].
    Dimković N; Ramić Z; Djukanović Lj; Trbolević S; Lukić M
    Srp Arh Celok Lek; 1990; 118(11-12):435-40. PubMed ID: 2133597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating inhibitor of interleukin 1 activity in patients with chronic renal diseases.
    Ramić Z; Dimković N; Djukanović L; Lazić M; Stepanović S; Simić M; Lukić ML
    Eur J Clin Invest; 1992 Oct; 22(10):681-6. PubMed ID: 1459172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The level of interleukin-2 and of soluble interleukin-2 receptor in patients with Balkan nephropathy.
    Vöö S; Drugărin D; Mărgineanu F; Koreck A; Negru S; Biriescu A
    Roum Arch Microbiol Immunol; 2002; 61(3):207-16. PubMed ID: 14752984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical aspects and renal function in patients with endemic nephropathy].
    Bukvić D; Djukanović L; Janković S
    Srp Arh Celok Lek; 2003; 131(1-2):10-6. PubMed ID: 14608855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic studies in patients with glomerulonephritis.
    Belovezhdov N; Altankova I
    Clin Nephrol; 1982 Mar; 17(3):141-8. PubMed ID: 7067176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studying the immune reactivity of uremic patients by phytohemagglutinin-stimulated lymphocyte culture].
    Petri I; Gál G; Kaiser G; Maráz A
    Orv Hetil; 1974 Mar; 115(11):613-5. PubMed ID: 4815461
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical importance of lymphocyte blast transformation to specific and nonspecific mitogens in kidney pathology in children].
    Petrenko NM
    Pediatr Akus Ginekol; 1978; (3):15-6. PubMed ID: 673503
    [No Abstract]   [Full Text] [Related]  

  • 8. Hemodialysis treatment in patients with Balkan endemic nephropathy: an epidemiological study.
    Cukuranovic R; Jovanovic I; Miljkovic S; Stefanovic N; Vlajkovic S; Prokopovic M; Stefanovic V
    Ren Fail; 2007; 29(7):805-10. PubMed ID: 17994447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Essential edema-proteinuria-hypertension (EPH) gestosis and gestosis superimposing pre-existing renal disease: comparison of cellular immunity parameters.
    Malinowski A; Szpakowski M; Tchórzewski H; Zeman K; Oszukowski P; Podciechowski L
    Arch Immunol Ther Exp (Warsz); 1994; 42(5-6):387-91. PubMed ID: 8572897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulated rat T cell-derived inhibitory factor for cellular DNA synthesis (STIF). III. Effect on cell proliferation and immune responses.
    Chiba K; Nishimura T; Hashimoto Y
    J Immunol; 1985 May; 134(5):3172-8. PubMed ID: 2580017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of age, basic disease and treatment of kidney patients in the stage of compensated retention on prognosis in a chronic hemodialysis program].
    Kron J; Arlt C
    Z Gesamte Inn Med; 1985 Oct; 40(20):591-5. PubMed ID: 4082679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-mediated mechanisms in renal diseases.
    McCluskey RT; Bhan AK
    Kidney Int Suppl; 1982 May; 11():S6-12. PubMed ID: 6750211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunologic suppressor factors in sera of patients with ovarian cancer].
    Li GT; Zhang SW; Zhong SY
    Zhonghua Fu Chan Ke Za Zhi; 1994 Jul; 29(7):392-4, 443. PubMed ID: 8001413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycoprotein-adsorption from cancer sera--influence on a mixed lymphocyte culture.
    Richner J; Schuff-Werner P; Bätge R; Beyer JH; Nagel GA
    J Clin Lab Immunol; 1985 Oct; 18(2):75-9. PubMed ID: 2934552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Release of the serum immunosuppressive factor by monocytes in patients with Crohn's disease.
    Watanabe M; Hibi T; Iwao Y; Kanai T; Ohara M; Fujisawa T; Ogata H; Watanabe N; Asakura H; Aiso S
    J Clin Lab Immunol; 1989 Aug; 29(4):161-6. PubMed ID: 2637362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of in vitro mitogen-induced lymphoproliferative responses by sera from F344 rats with large granular lymphocyte leukemia.
    Stromberg PC; McMurray DN; Brown CA
    J Clin Lab Immunol; 1988 Feb; 25(2):89-95. PubMed ID: 3259632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence of circulating anti-tubular basement membrane-antibody in renal diseases, and clinical observations.
    Lindqvist B; Lundberg L; Wieslander J
    Clin Nephrol; 1994 Apr; 41(4):199-204. PubMed ID: 8026111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inhibitory serum factors in MLR and in PHA-stimulation in sera from normal, allogenic hyperimmunized and transplantation tolerant mice].
    Brock J; Siegl E; Schulze HA; Görz R
    Allerg Immunol (Leipz); 1986; 32(4):287-94. PubMed ID: 2951994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Variation of serum proteins in kidney diseases].
    Ueda Y; Takamiya Y; Minami S; Ishimoto F; Isonishi H
    Saishin Igaku; 1968 Aug; 23(8):1607-15. PubMed ID: 4178368
    [No Abstract]   [Full Text] [Related]  

  • 20. Serial changes in humoral and cellular immunity induced by prostaglandin E2 treatment of murine immune complex glomerulonephritis.
    McLeish KR; Stelzer GT; Eades DS; Cohen R; Wallace JH
    J Lab Clin Med; 1985 Nov; 106(5):517-23. PubMed ID: 2932513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.